Equities

OptimizeRx Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
OPRX:NAQ

OptimizeRx Corp

Actions
Health CareHealth Care Providers
  • Price (USD)7.32
  • Today's Change-0.07 / -0.95%
  • Shares traded257.09k
  • 1 Year change+50.31%
  • Beta1.2357
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

  • Revenue in USD (TTM)109.51m
  • Net income in USD34.00k
  • Incorporated2008
  • Employees106.00
  • Location
    OptimizeRx Corp260 CHARLES STREET, SUITE 302WALTHAM 02453United StatesUSA
  • Phone+1 (248) 651-6558
  • Fax+1 (248) 453-5529
  • Websitehttps://www.optimizerx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rekor Systems Inc49.03m-44.04m118.39m319.00--3.01--2.41-0.4258-0.42580.44210.2880.53835.775.15153,692.80-48.34-58.23-64.73-69.9553.9451.67-89.82-190.451.20-13.120.3134--31.7653.12-34.42--15.85--
Definitive Healthcare Corp241.52m-138.93m119.10m686.00--0.5773--0.4931-1.25-1.252.261.970.2647--4.59352,071.40-21.84-13.90-31.98-19.5675.8878.50-82.52-102.90---2.520.3031---4.2415.3466.37--64.34--
Diginex Ltd3.57m-9.86m122.12m27.00--10.75--34.25-0.0523-0.05230.0190.05390.4415--2.67155,009.10-122.06---1,387.59-------276.48------0.0206--57.02---7.01------
Health Catalyst Inc316.06m-107.62m128.49m728.00--0.3575--0.4066-1.58-1.584.674.700.4515--5.66---15.37-17.22-21.77-20.4247.4947.29-34.05-45.30---3.160.3157--3.6014.6241.17--30.49--
Ton Strategy Co7.76m74.81m132.95m18.00--0.2081.7417.13-5.63-5.630.76310.820.0227----431,111.1022.39-79.4622.79-166.2474.4855.48986.60-469.61----0.00--1,320.64-37.1123.56--24.00--
OPTIMIZERx Corp109.51m34.00k137.75m106.005,204.231.1231.471.26-0.0027-0.00275.816.580.6528--3.741,033,076.000.0203-8.040.0225-8.8665.3160.780.031-15.40--1.290.1869--28.8130.23-14.48---22.29--
Arena Group Holdings Inc142.82m30.49m141.31m190.004.64--3.590.98950.63982.653.00-0.21481.21--5.49751,657.9025.88-31.09---186.5952.5937.4121.35-36.09--3.721.10---12.3418.7479.40--14.00--
Zapata Quantum Inc0.001.47m142.81m6.00---------0.0498-0.04980.00-0.15880.00----0.0029.78-----------------4.91-----31.80---28.28------
Lucent Inc-100.00bn-100.00bn145.36m--------------------------------------------------------------
Marti Technologies Inc24.58m-71.29m157.42m442.00------6.41-1.17-1.170.3698-0.94151.168.3646.6155,604.28-337.71---916.85--26.87---290.07--0.7927-5.118.45---6.84---118.49------
Repositrak Inc23.50m7.01m157.46m69.0023.623.1719.346.700.36620.36621.232.730.4233--5.02340,612.9013.0910.2114.7811.6184.9979.7730.9226.33----0.008114.9010.532.4422.3645.73-52.35--
Duos Technologies Group Inc19.03m-10.04m158.86m79.00--3.12--8.35-0.9422-0.94221.552.440.414418.287.35240,839.40-21.88-67.07-26.36-115.5726.389.12-52.79-90.373.80-23.470.0009---2.55-11.804.25--53.01--
Domo Inc318.00m-69.05m164.27m888.00------0.5166-1.72-1.727.90-4.591.62--5.81358,110.40-35.25-39.31---1,451.3974.3974.98-21.71-31.84---2.05-----0.609712.83-8.42--7.66--
Data as of Mar 03 2026. Currency figures normalised to OptimizeRx Corp's reporting currency: US Dollar USD

Institutional shareholders

41.03%Per cent of shares held by top holders
HolderShares% Held
Whetstone Capital Advisors LLCas of 31 Dec 20251.51m8.09%
BlackRock Fund Advisorsas of 31 Dec 20251.08m5.80%
The Vanguard Group, Inc.as of 31 Dec 20251.01m5.41%
Royce & Associates LPas of 31 Dec 2025682.03k3.66%
Kennedy Capital Management LLCas of 31 Dec 2025673.92k3.62%
Rice, Hall, James & Associates LLCas of 31 Dec 2025590.67k3.17%
William Blair & Co. LLC (Investment Management)as of 31 Dec 2025582.59k3.13%
Parkman Healthcare Partners LLCas of 31 Dec 2025538.65k2.89%
Next Century Growth Investors LLCas of 31 Dec 2025505.41k2.71%
SSgA Funds Management, Inc.as of 31 Dec 2025477.53k2.56%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.